Maximum quantity allowed is 999
Please select the quantity
CAS RN: 90098-04-7 | Product Number: R0085
Rebamipide
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid
Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 1G |
$73.00
|
37 | 14 |
| 5G |
$187.00
|
15 | 20 |
| 25G |
$579.00
|
15 | ≥40 |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 95.0 % |
Properties (reference)
| Melting Point | 290 °C(dec.) |
GHS
Related Laws:
| RTECS# | VC2518500 |
Transport Information:
| H.S.code* | 2933.49-000 |
Application
Rebamipide: A Quinolinone Analog for Gastric Mucosal Protection
Rebamipide (OPC-12759), a 2(1H)-quinolinone analog, is used as an anti-gastritis and anti-gastric ulcer agent. It has been reported to have various activities in the gastric mucosa, such as stimulation of prostaglandin and mucus glycoprotein synthesis, inhibition of reactive oxygen species, inflammatory cytokines and chemokines, and inhibition of neutrophils activation. Furthermore, inhibition of gastric tumor growth by rebamipide has also been reported. In addition, rebamipide is used as a therapeutic adjunct for the treatment of infections caused by Helicobacter pylori. For your reference, we also have a related synthetic intermediate [O0468] of rebamipide. (The product is for research purpose only.)
References
- Studies on 2 (1H)-Quinolinone Derivatives as Gastric Antiulcer Active Agents. 2-(4-Chlorobenzoylamino)-3-[2 (1H)-quinolinon-4-yl] propionic Acid and Related Compounds
- Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat
- Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study
- 15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New Applications (a review)
- Rebamipide: a gastrointestinal protective drug with pleiotropic activities (a review)
- Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form
Application
Induction of Cyclooxygenase-2 (COX-2) in Rat Gastric Mucosa by Rebamipide
Reference
- Induction of Cyclooxygenase-2 in Rat Gastric Mucosa by Rebamipide, a Mucoprotective Agent
- M. Yasumaru, H. Iijima, Y. Okuda, Y. Sasaki, M. Hori, S. Kawano, J. Pharmacol. Exp. Ther. 2000, 295, 447.
PubMed Literature
Articles/Brochures
TCIMAIL
Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.